DarioHealth Signs 85 Contracts for $12.9M, Eyes $38-42M Break-Even Revenue
DarioHealth signed 85 new agreements worth $12.9 million in Q4 2025, with rollouts underway and revenue growth expected to quicken in H2 2026. The company aims for cash-flow positivity at $38-42 million revenue, plans a 30% non-GAAP operating loss reduction in 2026, and cites cost cuts via AI and payer partnerships.
1. New Contract Wins
DarioHealth secured 85 new agreements in Q4 2025 totaling $12.9 million, with some already in implementation. Management expects this backlog to drive revenue acceleration in the second half of 2026.
2. Path to Profitability
The company plans to achieve cash-flow positivity once revenues reach $38-42 million, with a 30% reduction in non-GAAP operating loss targeted for 2026 through cost optimization and AI-driven efficiencies.
3. Strategic Partnerships and Business Model
DarioHealth highlighted its role as a preferred in-network partner for HCSC and alliances with UnitedHealthcare and Amwell, enabling scalable access to millions of covered lives via curated digital health networks.